#IDDF2025

Programme

Room N101B
2025-07-05
09:00-10:30
State Key Lab Meeting (1): Microbiome and Cancer
09:00
To be confirmed
09:25
Using genetics to explore microbe-host interactions at the molecular level
09:50
Gut microbiome dynamics in MASLD: Implications for liver cancer
10:15
Q & A
Room N101B
2025-07-05
11:00-12:30
State Key Lab Meeting (2): Microbiome/Metabolites, Gut-liver Axis and Liver Diseases
11:00
To be confirmed
Room N101B
2025-07-05
12:30-14:00
Lunch Symposium (B)
12:30
Lunch Symposium
Room N101B
2025-07-05
15:50-17:20
Hepatology Session (1): Viral Hepatitis
15:50
From hepatic steatosis to cancer: The role of metabolism in chronic hepatitis B
16:15
Long-term safety of oral nucleos(t)ide analogues
16:40
The road to 2030: Can Asia achieve viral hepatitis elimination?
17:05
Q & A
Room N101B
2025-07-05
17:20-18:20
Hepatology Session (2): Metabolic Dysfunction-associated Steatotic Liver Disease
17:20
Insights from recent omics studies on MASLD pathogenesis and management
17:45
Are incretin therapies the definitive solution for MASH?
18:10
Q & A
Room N111 & 12
2025-07-06
10:20-11:30
Greater China Meeting (7)
Chair : Chao-hui YU, Xue-mei LIU and Hon-ho YU
10:20
VCTE
10:40
Autoimmune liver disease
11:00
Fatty liver disease
11:20
Discussion Session
State Key Lab Meeting (1): Microbiome and Cancer
Room N101B
2025-07-05
09:00
09:00
To be confirmed
09:25
Using genetics to explore microbe-host interactions at the molecular level
09:50
Gut microbiome dynamics in MASLD: Implications for liver cancer
10:15
Q & A
State Key Lab Meeting (2): Microbiome/Metabolites, Gut-liver Axis and Liver Diseases
Room N101B
2025-07-05
11:00
11:00
To be confirmed
Lunch Symposium (B)
Room N101B
2025-07-05
12:30
12:30
Lunch Symposium
Hepatology Session (1): Viral Hepatitis
Room N101B
2025-07-05
15:50
15:50
From hepatic steatosis to cancer: The role of metabolism in chronic hepatitis B
16:15
Long-term safety of oral nucleos(t)ide analogues
16:40
The road to 2030: Can Asia achieve viral hepatitis elimination?
17:05
Q & A
Hepatology Session (2): Metabolic Dysfunction-associated Steatotic Liver Disease
Room N101B
2025-07-05
17:20
17:20
Insights from recent omics studies on MASLD pathogenesis and management
17:45
Are incretin therapies the definitive solution for MASH?
18:10
Q & A
Greater China Meeting (7)
Room N111 & 12
2025-07-06
10:20
Chair : Chao-hui YU, Xue-mei LIU and Hon-ho YU
10:20
VCTE
10:40
Autoimmune liver disease
11:00
Fatty liver disease
11:20
Discussion Session
About IDDF
The Organizer
The Organizing Committee
The Project Team
Venue
Follow Us
#IDDF2025
ATTENDING IDDF
Submit Abstracts
Submit Case Reports
Register
Accreditation
PARTNERSHIP
Sponsors
Supporting Organization
MORE
Privacy Policy
Disclaimer
Contact Us
About IDDF
The Organizer
The Organizing Committee
The Project Team
Venue
ATTENDING IDDF
Submit Abstracts
Submit Case Reports
Register
Accreditation
Programme
Speaker
PARTNERSHIP
Sponsors
Supporting Organization
MORE
Privacy Policy
Disclaimer
Contact Us
Follow Us
#IDDF2025
SECRETARIAT
MIMS (Hong Kong) Limited

Unit 2606-2609, 26/F, AIA Tower, 183 Electric Road,
North Point, Hong Kong
‍
E: info@iddforum.com
T: (852) 2116 4320
F: (852) 2559 6910
Organizers
PATRON:
Copyright © 2025. All Rights Reserved. Institute of Digestive Disease, The Chinese University of Hong Kong. Privacy | Disclaimer